Search

Your search keyword '"Inker, Lesley"' showing total 72 results

Search Constraints

Start Over You searched for: Author "Inker, Lesley" Remove constraint Author: "Inker, Lesley" Publisher ovid technologies (wolters kluwer health) Remove constraint Publisher: ovid technologies (wolters kluwer health)
72 results on '"Inker, Lesley"'

Search Results

1. Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies – Perspectives from the ASON

2. Assessment of Glomerular Filtration Rate in Patients with Cancer: A Statement from the American Society of Onco-Nephrology

3. VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of Chronic Kidney Disease in Patients with Metabolic Acidosis

6. Change in Albuminuria and GFR Slope as Joint Surrogate Endpoints for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD

7. Social Determinants of Health and Their Impact on the Black Race Coefficient in Serum Creatinine–Based Estimation of GFR

13. The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts

15. Effects of Bardoxolone Methyl in Alport Syndrome

19. Hemoconcentration of Creatinine Minimally Contributes to Changes in Creatinine during the Treatment of Decompensated Heart Failure

23. A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease

25. Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force

28. Short‐Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial

31. GFR in Healthy Aging: an Individual Participant Data Meta-Analysis of Iohexol Clearance in European Population-Based Cohorts

36. Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data

37. GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials

38. Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation

39. Serum and Urine Albumin and Response to Loop Diuretics in Heart Failure

44. Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy

48. Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD

49. Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression

50. Abstract MP07: Soluble Urokinase-type Plasminogen Activator Receptor is associated with progression of hypertension-attributed chronic kidney disease in African Americans

Catalog

Books, media, physical & digital resources